Serum Vitamin D Levels as Biomarkers in Patients with Autoimmune Uveitis and their Possible Correlation with Disease Activity.
Karine KollerKimble Matos Teixeira FonsecaKelsy N ArecoYuslay Fernández ZamoraLuci Meire Pereira SilvaRicardo-Pedro Casaroli-MaranoCicero Galli CoimbraCristina MuccioliPublished in: Ocular immunology and inflammation (2023)
This study investigated the correlation between serum vitamin D levels and intraocular inflammation in patients with autoimmune uveitis (AIU). We evaluated 67 patients with active and inactive AIU and measured their serum 25-hydroxyvitamin D [25(OH)D] concentration, sun exposure habits, number of relapses, and complications. Of the patients evaluated, 85% had significantly lower vitamin D levels, and patients with active uveitis had lower 25(OH)D levels than those with inactive uveitis. The odds of developing active uveitis decreased by 6% with each 1-unit increase in 25(OH)D. Patients with recurrent active AIU had significantly lower 25(OH)D serum levels than inactive forms, indicating that low vitamin D levels may alter the clinical course of intraocular inflammation in AIU. Additionally, the study found that a higher mean BMI increased the chances of an individual having active uveitis by 14%. These results suggest that serum vitamin D concentration could be a prognostic clinical biomarker in AIU.
Keyphrases
- juvenile idiopathic arthritis
- ankylosing spondylitis
- disease activity
- rheumatoid arthritis
- systemic lupus erythematosus
- oxidative stress
- end stage renal disease
- multiple sclerosis
- chronic kidney disease
- rheumatoid arthritis patients
- ejection fraction
- newly diagnosed
- high resolution
- prognostic factors
- risk factors
- patient reported outcomes
- patient reported
- high speed